|
Six-month patient-reported outcome (PRO) results from AQUARiUS, a prospective, observational, multicenter phase 4 study in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving abiraterone acetate + prednisone (AAP) or enzalutamide (ENZ). |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; Bayer; Ipsen; Janssen; Merck; Novartis |
Consulting or Advisory Role - Janssen; Novartis |
Research Funding - Astellas Pharma; Janssen; MOLOGEN; MSD |
|
|
Stock and Other Ownership Interests - Novo Nordisk |
Honoraria - Janssen-Cilag |
Consulting or Advisory Role - Janssen-Cilag |
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Sanofi |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; Bristol-Myers Squibb |
Consulting or Advisory Role - Clovis Oncology |
Travel, Accommodations, Expenses - Astellas Pharma; Clovis Oncology; Ipsen; Janssen |
|
|
No Relationships to Disclose |
|
|
Honoraria - Janssen-Cilag |
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer Schering Pharma; Janssen Oncology; Roche; Sanofi |
|
|
Honoraria - Astellas Pharma; Ferring; Ipsen; Janssen |
Consulting or Advisory Role - Astellas Pharma; Ferring; Ipsen; Janssen |
Travel, Accommodations, Expenses - Astellas Pharma; Bouchara Recordati; Ferring; Ipsen; Janssen |
|
|
|
|
|
|
|
|
|
|
|
Honoraria - Astellas Pharma (I); Janssen; Janssen (I) |
Consulting or Advisory Role - Abbott Laboratories (I); Astellas Pharma (I); Bayer (I); ESSA (I); Janssen-Cilag (I); Medivation (I); Millenium Pharamceuticals (I); Novartis (I); Ventana Medical Systems (I); Veridex (I) |
Speakers' Bureau - Astellas Pharma (I); Janssen (I); Sanofi (I); Takeda (I); Ventana Medical Systems (I) |
Research Funding - Arno Therapeutics (I); AstraZeneca (I); Innocrin Pharma (I); Janssen |
Travel, Accommodations, Expenses - Abbott Laboratories (I); Astellas Pharma; Astellas Pharma (I); Bayer (I); ESSA (I); Janssen; Janssen (I); Medivation (I); Ventana Medical Systems (I) |
Other Relationship - Institute of Cancer Research; Institute of Cancer Research (I) |